DEPLOYDatabase

Deployment

RNS System at United States (comprehensive epilepsy centers nationwide)

FDA-approved implantable responsive neurostimulation system for focal epilepsy. Continuously monitors and responds to abnormal brain activity.

RNS System by NeuroPace · Catalog entry · 1 source · not yet field-verified · Biometric wearables

Track RNS System at United States (comprehensive epilepsy centers nationwide)

Recent coverage

See all coverage →

RNS System available at most comprehensive epilepsy centers (CECs) throughout the United States. FDA-approved November 2013 for drug-resistant focal epilepsy. AdventHealth Orlando, University of Miami, and many other hospitals implant patients. First FDA-approved RNS device.

Safety record

No incidents on record for RNS System at United States (comprehensive epilepsy centers nationwide).

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Trust tier
Catalog entry · 1 source · not yet field-verifiedhow tiers work →
Last updated
2026-08-14
Model
RNS System
Company
NeuroPace
Location
United States (comprehensive epilepsy centers nationwide)
Status
operational
First seen
2013-11-01
ID
6299a051-291f-4a0b-a278-38a13c2a78cf

Timeline

  1. Nov 2013
    First recorded
    RNS System first documented operating at United States (comprehensive epilepsy centers nationwide).
  2. Aug 2026
    Current status: operational, reviewed
    Latest recorded state. New status transitions append here as the deployment-status recorder produces them.

On the deployment map

Operates worldwide

RNS System is deployed globally rather than at a single verified site, so there is no map pin.

Free to use on your site, with a link back to DEPLOY.

RNS System operates in United States (comprehensive epilepsy centers nationwide). Explore the full verified map:

Sources (1)

  1. https://www.neuropace.com/patients/neuropace-rns-system/
Methodology: Verified · 1 source (no primary) · last reviewed 2026-08-14

Verification posture

Verified

Low confidence

Review state

Stable

Last reviewed 2026-08-14

Maturity + lifecycle

Maturity stage: commercial

Lifecycle: active

Architectural position

Cohort: biometric

Sources by quality tier

1
unclassified
Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for RNS System at United States (comprehensive epilepsy centers nationwide).

Common questions

What is the RNS System deployment at United States (comprehensive epilepsy centers nationwide)?
RNS System, built by NeuroPace, is recorded as a deployment at United States (comprehensive epilepsy centers nationwide) on the DEPLOY registry. NeuroPace operates the deployment directly.
Who operates RNS System at United States (comprehensive epilepsy centers nationwide)?
NeuroPace, the manufacturer of RNS System, operates this deployment directly. This is a maker-deploys-its-own-product arrangement rather than a customer pilot.
When did the RNS System deployment at United States (comprehensive epilepsy centers nationwide) go live?
The deployment is recorded as starting November 1, 2013 on the DEPLOY registry. Earlier activity may exist but is not yet sourced.
Have there been incidents at the RNS System deployment at United States (comprehensive epilepsy centers nationwide)?
No active incidents affecting this deployment are recorded on the DEPLOY registry. Absence of recorded incidents is not a guarantee no incident occurred; DEPLOY records only sourced incidents and suppresses retracted ones.

Deploy Watch

Track this deployment.

We notify you when status changes against primary-source evidence, contract events surface, or a related incident is filed.

Machine-readable surfaces